Colchicine NDC 31722-899

NDC codes

FDA NDC Directory

Product NDC (as listed)31722-899Labeler and product segments. Claims need a package NDC.

Product NDC at billing width31722-0899Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
31722-899-01	31722089901	100 TABLET, FILM COATED in 1 BOTTLE (31722-899-01)Marketed from Aug 13, 2021
31722-899-30	31722089930	30 TABLET, FILM COATED in 1 BOTTLE (31722-899-30)Marketed from Aug 13, 2021

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Colchicine
Generic name (nonproprietary): colchicine
Active ingredients: Colchicine — .6 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Camber Pharmaceuticals, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 208993
Marketing start: Aug 13, 2021
Listing expires: Dec 31, 2026
Other FDA classes: Cytochrome P450 3A4 Inhibitors (Mechanism)P-Glycoprotein Interactions (Mechanism)
Identifiers: Product ID 31722-899_c9c0c7c1-6f07-596e-e053-2995a90aae1eSPL ID c9c0c7c1-6f07-596e-e053-2995a90aae1eSPL set ID 1e7ef16d-262b-4dc0-92d6-7afe4aa21ebdRxCUI 197541UNII SML2Y3J35TUPC 0331722899307

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N431722089901 followed by a unit qualifier and the quantity

Package 31722-0899-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 17, 2021.

Indications (excerpt from the label)

Colchicine tablets are an alkaloid indicated for: • Prophylaxis and treatment of gout flares in adults (1.1). • Familial Mediterranean fever (FMF) in adults and children 4 years or older (1.2). 1.1 Gout Flares Colchicine tablets are indicated for prophylaxis and the treatment of acute gout flares. • Prophylaxis of Gout Flares: Colchicine tablets are indicated for prophylaxis of gout flares. • Treatment of Gout Flares: Colchicine tablets are indicated for treatment of acute gout flares when taken at the first sign of a flare. 1.2 Familial Mediterranean Fever (FMF) Colchicine tablets are indicated in adults and children four years or older for treatment of familial Mediterranean fever (FMF).…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 208993

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 208993
Product	Strength	Form · route	Labeler	Product NDC
Colchicine	Colchicine .6 mg/1	Tablet, Film coatedOral	Direct_Rx	72189-687
Colchicine	Colchicine .6 mg/1	Tablet, Film coatedOral	PD-Rx Pharmaceuticals, Inc.	72789-572
Colchicine	Colchicine .6 mg/1	Tablet, Film coatedOral	Bryant Ranch Prepack	71335-2791